Levying an opioid impact fee on opioid manufacturers to fund behavioral health services.

Washington HB2072 creates an opioid impact fee on manufacturers of prescription opioids. The fee is one cent per morphine milligram equivalent for opioids dispensed in the state. The revenue from this fee is deposited into the Prescription Opioid Impact Account. Funds from this account are used to support behavioral health programs, with a focus on children, youth, and young adults. The act also mandates that manufacturers who dispense over 100,000 morphine milligram equivalents in a quarter receive a quarterly statement and must pay the fee within 45 days or face penalties.

Levying an opioid impact fee on opioid manufacturers to fund behavioral health services.

Washington HB2072 creates an opioid impact fee on manufacturers of prescription opioids. The fee is one cent per morphine milligram equivalent for opioids dispensed in the state. The revenue from this fee is deposited into the Prescription Opioid Impact Account. Funds from this account are used to support behavioral health programs, with a focus on children, youth, and young adults. The act also mandates that manufacturers who dispense over 100,000 morphine milligram equivalents in a quarter receive a quarterly statement and must pay the fee within 45 days or face penalties.